5-[3-[(4-aminocyclohexyl)methyl-methylamino]-4-(trifluoromethyl)phenyl]-3H-1,3,4-oxadiazol-2-one;hydrochloride
C17H22ClF3N4O2 — CID 156761229
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[3-[(4-aminocyclohexyl)methyl-methylamino]-4-(trifluoromethyl)phenyl]-3H-1,3,4-oxadiazol-2-one;hydrochloride
5-[3-[(4-aminocyclohexyl)methyl-methylamino]-4-(trifluoromethyl)phenyl]-3H-1,3,4-oxadiazol-2-one;hydrochloride (PubChem CID 156761229) has the molecular formula C17H22ClF3N4O2 and a molecular weight of 406.84 g/mol. Its IUPAC name is 5-[3-[(4-aminocyclohexyl)methyl-methylamino]-4-(trifluoromethyl)phenyl]-3H-1,3,4-oxadiazol-2-one;hydrochloride.
Molecular Properties
| Compound Name | 5-[3-[(4-aminocyclohexyl)methyl-methylamino]-4-(trifluoromethyl)phenyl]-3H-1,3,4-oxadiazol-2-one;hydrochloride |
|---|---|
| PubChem CID | 156761229 |
| Molecular Formula | C17H22ClF3N4O2 |
| Molecular Weight | 406.84 g/mol |
| Exact Mass | 406.14 |
| IUPAC Name | 5-[3-[(4-aminocyclohexyl)methyl-methylamino]-4-(trifluoromethyl)phenyl]-3H-1,3,4-oxadiazol-2-one;hydrochloride |
| SMILES | CN(CC1CCC(N)CC1)c1cc(-c2n[nH]c(=O)o2)ccc1C(F)(F)F.Cl |
| InChI | InChI=1S/C17H21F3N4O2.ClH/c1-24(9-10-2-5-12(21)6-3-10)14-8-11(15-22-23-16(25)26-15)4-7-13(14)17(18,19)20;/h4,7-8,10,12H,2-3,5-6,9,21H2,1H3,(H,23,25);1H |
| InChIKey | CCNFRIAVCAZSSU-UHFFFAOYSA-N |
| XLogP | 3.42 |
| TPSA | 88.15 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 406.84 |
| LogP ≤ 5 | 3.42 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156761229 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.